AI Article Synopsis
- The study investigates the gastro-protective effects of olmesartan (OLM) and its niosomal form (OLM-NIO) against indomethacin-induced gastric ulcers in rats.
- OLM-NIO demonstrated high entrapment efficiency and favorable release characteristics, contributing to enhanced gastro-protection compared to OLM alone.
- The research indicates that OLM promotes protective pathways against oxidative stress and inflammation, suggesting its potential as an effective treatment for gastric ulcers.
Article Abstract
Aims: Gastric ulcer is a continuous worldwide threat that inquires protective agents. Olmesartan (OLM) has potent anti-oxidant and anti-inflammatory characters, yet having limited bioavailability. We targeted the gastro-protective potential and probable mechanism of OLM and its niosomal form against indomethacin (IND) induced-gastric ulcer in rats.
Main Methods: we prepared OLM niosomes (OLM-NIO) with different surfactant: cholesterol molar ratios. We evaluated particle size, zeta-potential, polydispersity, and entrapment efficiency. In-vitro release study, Fourier transform infrared spectroscopy, differential scanning calorimetry, and transmission electron microscopy were performed for selected niosomes. In-vivo, we used oral Omeprazole (30 mg/kg), OLM or OLM-NIO (10 mg/kg) for 3 days before IND (25 mg/kg) ingestion. We assessed gastric lesions, oxidative and inflammatory markers.
Key Findings: OLM-NIO prepared with span 60:cholesterol ratio (1:1) showed high entrapment efficiency 93 ± 2%, small particle size 159.3 ± 6.8 nm, low polydispersity 0.229 ± 0.009, and high zeta-potential -35.3 ± 1.2 mV, with sustained release mechanism by release data. In-vivo macroscopical and histological results showed gastro-protective effects of OLM pretreatment, which improved oxidative stress parameters and enhanced the gastric mucosal cyclooxygenase-1 (COX-1) and prostaglandin E2 (PGE2) contents. OLM pretreatment suppressed interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) contents and translocation of p38 mitogen-activated protein kinase (p38-MAPK). Besides, OLM substantially promoted the nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) protective pathway. OLM-NIO furtherly improved all previous outcomes.
Significance: We explored OLM anti-ulcerative effects, implicating oxidative stress and inflammation improvement, mediated by the Nrf2/HO-1 signaling pathway and p38-MAPK translocation. Meanwhile, the more bioavailable OLM-NIO achieved better gastro-protective effects compared to conventional OLM form.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11095-021-03126-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inclusion of Ora-Pro-Nóbis () Leaf Meal in the Diet of Adult Nile Tilapia Improves Growth Performance and Intestinal Absorption Capacity Without Compromising Metabolic and Hematological Variables.
Vet Sci
January 2025
Graduate Program in Animal Science, Federal University of Paraná, 1540 Rua dos Funcionários, Cabral, Curitiba 80035-050, PR, Brazil.
Corn and soybeans are commodities and ingredients of global interest, whose prices fluctuate based on global demands. In this sense, this study aimed to assess ora-pro-nóbis ( leaf meal (OLM) as an alternative to be included in the diets of Nile tilapia (). The optimal inclusion level of OLM in tilapia diets is investigated herein, aiming to improve their growth performance and health.
View Article and Find Full Text PDFHost-Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients.
Pharmaceutics
December 2024
Faculty of Pharmacy, "Victor Babeş" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
Olmesartan medoxomil (OLM) is the prodrug of olmesartan, an angiotensin II type 1 receptor blocker that has antihypertensive and antioxidant activities and renal protective properties. It exhibits low water solubility, which leads to poor bioavailability and limits its clinical potential. To improve the solubility of OLM, a host-guest inclusion complex (IC) between heptakis(2,6-di-O-methyl)-β-cyclodextrin (DMβCD) and the drug substance was obtained.
View Article and Find Full Text PDFOverlapping Systemic Proteins in COVID-19 and Lung Fibrosis Associated with Tissue Remodeling and Inflammation.
Biomedicines
December 2024
Lung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
A novel patient group with chronic pulmonary fibrosis is emerging post COVID-19. To identify patients at risk of developing post-COVID-19 lung fibrosis, we here aimed to identify systemic proteins that overlap with fibrotic markers identified in patients with idiopathic pulmonary fibrosis (IPF) and may predict COVID-19-induced lung fibrosis. Ninety-two proteins were measured in plasma samples from hospitalized patients with moderate and severe COVID-19 in Sweden, before the introduction of the vaccination program, as well as from healthy individuals.
View Article and Find Full Text PDFMetagenomic immunoglobulin sequencing reveals IgA coating of microbial strains in the healthy human gut.
Nat Microbiol
January 2025
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
IgA, the primary human antibody secreted from the gut mucosa, shapes the intestinal microbiota. Methodological limitations have hindered defining which microbial strains are targeted by IgA and the implications of binding. Here we develop a technique, metagenomic immunoglobulin sequencing (MIg-seq), that provides strain-level resolution of microbes coated by IgA and use it to determine IgA coating levels for 3,520 gut microbiome strains in healthy human faeces.
View Article and Find Full Text PDFPosterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study.
Neuroimage Clin
December 2024
Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address:
Background: Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD+) contributes to MTL-specific patterns of degeneration.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!